NAMSA has extensive experience with combination products, tissue/ biologics, regenerative medicine, cellular therapy and tissue engineering therapies. Our experience with these types of therapies is what has, in part, made us a premier contract research organization (CRO).
In addition, NAMSA’s highly skilled and experienced regulatory and quality consultants have a long history of successful submissions and practical, effective quality system development. We’ve conducted beneficial gap analyses and audits for regenerative medicine, cellular therapy and tissue engineering companies as well.